This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by September 19 to save $600

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Xin Zhang, PhD
Principal Scientist at Denali Therapeutics
Speaker

Profile

Dr. Xin Zhang is a Principal Scientist and analytical team leader at Denali Therapeutics with more than 15 years of experience in the pharmaceutical and biopharma industry. She specializes in the characterization of antisense oligonucleotides (ASOs), antibody–oligonucleotide conjugates (AOCs), and biologics, with expertise spanning metabolism, stability, and pharmacokinetics. Dr. Zhang earned her Ph.D. in Analytical Chemistry from the University at Buffalo, SUNY, and is a co-inventor on several U.S. patents.